Triamcinolone Acetonide
Regulatory milestones approvals, filings & regulatory actions · 8 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | ZILRETTA | — | 2019-12-23 | fda.gov ↗ |
| Label expansions (4) | US (FDA) | NASACORT ALLERGY 24 HOUR | — | 1997-09-26 – 2013-10-11 | fda.gov ↗ |
| Label expansion | US (FDA) | AZMACORT | — | 1996-10-30 | fda.gov ↗ |
| Label expansion | US (FDA) | NASACORT | — | 1996-05-20 | fda.gov ↗ |
| Approved | US (FDA) | TRIAMCINOLONE ACETONIDE | — | 1958-10-23 | fda.gov ↗ |
Trials 176 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials | ||||||
| Phase 0 | NCT06634823 | Dec 2024 → Jun 2026 overdue | laryngeal disorder | Medical University of South Carolina | Recruiting | No outcome recorded |
| Phase 0 | NCT04690608 | Dec 2024 | retinal edema | Tanta University | Unknown | No outcome recorded |
| Phase 0 | NCT07145008 | Sep 2024 → Jun 2025 overdue | macular retinal edema, uveitis | University of Baghdad | Recruiting | No outcome recorded |
| Phase 0 | NCT03445611 | Sep → Oct 2019 | osteoarthritis, knee | Loma Linda University | Withdrawn | No outcome recorded |
| Phase 0 | NCT00411333 | Jul 2006 → Jul 2009 | diabetic retinopathy | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 113 trials | ||||||
| Phase 1 | NCT05906433 | Jun 2023 → Jun 2025 overdue | osteoarthritis, knee | Foundation for Orthopaedic Research and Education | Recruiting | No outcome recorded |
| Phase 1 | NCT06681090 | Mar → Sep 2023 | lichen planus, oral | Al-Azhar University | Completed | No outcome recorded |
| Phase 1 | NCT04598542 | Oct → Dec 2020 | — | Biosplice Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT04261049 | Aug 2020 → Jan 2022 | osteoarthritis, knee | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 1 | NCT04658836 | Feb 2020 → Aug 2021 | acoustic neuroma | Medical University of Vienna | Completed | No outcome recorded |
| Phase 1 | NCT04831255 | Jun 2019 → Aug 2023 | frozen shoulder | University of Virginia | Terminated | No outcome recorded |
| Phase 1 | NCT03627741 | Jun 2018 → Jul 2022 | fibromatosis | Mayo Clinic | Completed | No outcome recorded |
| Phase 1 | NCT03248856 | Oct 2017 → Dec 2020 | hearing loss disorder | Christoph Arnoldner | Completed | No outcome recorded |
| Phase 1 | NCT00476918 | Jul 2006 → Dec 2007 | diabetic macular edema | Heidelberg University | Unknown | No outcome recorded |
| Phase 1 | NCT00915837 | Jun 2005 → Apr 2009 | diabetic macular edema | SurModics, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00371410 | Apr 2005 → Oct 2007 | diabetic macular edema | Samsung Medical Center | Completed | No outcome recorded |
| Phase 1 | NCT00101764 | Jan 2005 → May 2008 | diabetic retinopathy, macular degeneration, retinal vein occlusion | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 1 | NCT00071227 | Oct 2003 → Aug 2007 | macular degeneration, retinal vein occlusion | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 1/26 trials | ||||||
| Phase 1/2 | NCT06681688 | Jul 2024 → Jun 2025 overdue | cataract | Inder Paul Singh, M.D. | Recruiting | No outcome recorded |
| Phase 1/2 | NCT06230146 | May 2024 → Jan 2026 | keloid | Assiut University | Unknown | No outcome recorded |
| Phase 1/2 | NCT04326959 | Sep 2020 | keloid | PT. Prodia Stem Cell Indonesia | Unknown | No outcome recorded |
| Phase 1/2 | NCT01789320 | Feb 2013 → Mar 2015 | intermediate uveitis, panuveitis, posterior uveitis | Clearside Biomedical, Inc. | Completed | No outcome recorded |
| Phase 1/2 | NCT00801450 | Sep 2007 → Dec 2008 | diabetic macular edema | University of Sao Paulo | Unknown | No outcome recorded |
| Phase 1/2 | NCT00407849 | Oct 2006 → Dec 2007 | diabetic retinopathy | Federal University of São Paulo | Unknown | No outcome recorded |
| Phase 233 trials | ||||||
| Phase 2 | NCT07714525 | May 2026 → May 2027 expected | chronic rhinosinusitis, nasal cavity polyp | Deraya University | Recruiting | No outcome recorded |
| Phase 2 | NCT07540728 | Apr 2026 → Apr 2028 expected | sudden hearing loss disorder | Eye & ENT Hospital of Fudan University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07713329 | Mar → Jun 2026 | pleural empyema, respiratory tract infectious disorder | Delta University for Science and Technology | Completed | No outcome recorded |
| Phase 2 | NCT07134075 | Aug 2025 → Aug 2027 expected | sudden sensorineural hearing loss | Eye & ENT Hospital of Fudan University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06734975 | Jul 2025 → Dec 2026 expected | polyp of vocal cord | Rutgers, The State University of New Jersey | Recruiting | No outcome recorded |
| Phase 2 | NCT04744675 | May → Jul 2024 overdue | complex regional pain syndrome | Ottawa Hospital Research Institute | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06237153 | Nov 2023 → Dec 2025 overdue | osteoarthritis, hand | Marie Badalamente | Recruiting | No outcome recorded |
| Phase 2 | NCT05512962 | Aug 2022 → Nov 2023 | diabetic macular edema | Oxular Limited | Completed | No outcome recorded |
| Phase 2 | NCT04331002 | Aug 2020 → Jul 2022 | — | Austin V Stone | Terminated | No outcome recorded |
| Phase 2 | NCT04469075 | Jul 2020 → Jul 2026 overdue | glioblastoma, toxic dermatosis | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT04002362 | Nov 2019 → Jan 2025 | childhood onset asthma | Emory University | Completed | No outcome recorded |
| Phase 2 | NCT02637323 | Nov 2015 → Sep 2016 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 2 | NCT02221453 | Sep 2015 → Dec 2016 | diabetic macular edema | Unity Health Toronto | Completed | No outcome recorded |
| Phase 2 | NCT02465606 | Jul 2015 → May 2016 | atopic eczema | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 2 | NCT02303184 | Jan 2015 → Mar 2016 | macular retinal edema, retinal vein occlusion | Clearside Biomedical, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02255032 | Oct 2014 → Dec 2015 | anterior uveitis, intermediate uveitis, macular retinal edema, panuveitis +1 | Clearside Biomedical, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT02116972 | Apr 2014 → Nov 2015 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 2 | NCT01692756 | Mar 2013 → Feb 2017 | — | Cale Jacobs | Completed | No outcome recorded |
| Phase 2 | NCT01897259 | Mar 2012 → Jun 2019 | epicondylitis | Christine M. Kleinert Institute for Hand and Microsurgery | Unknown | No outcome recorded |
| Phase 2 | NCT07161778 | Oct 2011 → Sep 2020 | castration-resistant prostate carcinoma | Barts & The London NHS Trust | Completed | No outcome recorded |
| Phase 2 | NCT00890968 | Apr → Jun 2009 | hand dermatosis | ZARS Pharma Inc. | Completed | No outcome recorded |
| Phase 2 | NCT01797432 | Mar 2009 → Nov 2014 | alopecia areata | University of Minnesota | Completed | No outcome recorded |
| Phase 2 | NCT00473083 | Jan 2009 → Dec 2012 | exanthem | British Columbia Cancer Agency | Completed | No outcome recorded |
| Phase 2 | NCT00692614 | Jun → Nov 2008 | macular retinal edema | Merck Sharp & Dohme LLC | Terminated | No outcome recorded |
| Phase 2 | NCT00874744 | Mar → Sep 2008 | diabetic macular edema | Federal University of Goiás | Completed | No outcome recorded |
| Phase 2 | NCT01051648 | Dec 2007 → Feb 2008 | cataract, vitreous disorder | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT00484679 | May 2007 → Jun 2009 | alopecia areata | University of Minnesota | Completed | No outcome recorded |
| Phase 2 | NCT00464347 | Jan → Sep 2007 | age-related macular degeneration | National Eye Institute (NEI) | Terminated | No outcome recorded |
| Phase 2 | NCT00229918 | Sep 2005 → Sep 2006 | diabetic retinopathy | Edward Hines Jr. VA Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT00231023 | Sep 2005 → May 2006 | diabetic retinopathy | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 2 | NCT00369486 | Dec 2004 → Jun 2006 | diabetic macular edema | Jaeb Center for Health Research | Completed | No outcome recorded |
| Phase 2 | NCT00140803 | Oct 2003 → Jan 2007 | age-related macular degeneration | Manhattan Eye, Ear & Throat Hospital | Completed | No outcome recorded |
| Phase 2 | NCT00369863 | Jun 2002 → Jun 2003 | diabetic macular edema | Shahid Beheshti University of Medical Sciences | Completed | No outcome recorded |
| Phase 2/314 trials | ||||||
| Phase 2/3 | NCT06988527 | May 2025 → Jun 2026 overdue | atrophic lichen planus, oral erosive lichen | Dar Al Uloom University | Recruiting | No outcome recorded |
| Phase 2/3 | NCT03607175 | Jul 2023 → Sep 2025 | chronic rhinosinusitis, nasal cavity polyp | Marina Boruk | Unknown | No outcome recorded |
| Phase 2/3 | NCT05535738 | Nov 2022 → Jan 2027 expected | allergic contact dermatitis | Wei-Che Ko | Active not recruiting | No outcome recorded |
| Phase 2/3 | NCT05337332 | Apr 2022 → May 2023 | central serous chorioretinopathy, cystoid macular edema, pars planitis | Benha University | Unknown | No outcome recorded |
| Phase 2/3 | NCT05567081 | Jun 2021 → Apr 2022 | ulnar neuropathy | Tanta University | Completed | No outcome recorded |
| Phase 2/3 | NCT04744623 | Sep → Dec 2020 | mucous membrane pemphigoid | Tanta University | Unknown | No outcome recorded |
| Phase 2/3 | NCT05413330 | Sep 2020 → Jan 2022 | cataract, type 2 diabetes mellitus | Damascus University | Completed | No outcome recorded |
| Phase 2/3 | NCT05737173 | Aug 2020 → Sep 2022 | osteoarthritis, knee | Queen Savang Vadhana Memorial Hospital, Thailand | Completed | No outcome recorded |
| Phase 2/3 | NCT02328118 | Feb 2015 → Mar 2017 | proliferative diabetic retinopathy | JUNYAN ZHANG | Unknown | No outcome recorded |
| Phase 2/3 | NCT00853905 | Feb 2009 → Dec 2011 | glaucoma | Wills Eye | Completed | No outcome recorded |
| Phase 2/3 | NCT00532142 | Apr 2005 → Aug 2009 | central retinal vein occlusion | Rudolf Foundation Clinic | Completed | No outcome recorded |
| Phase 2/3 | NCT00443521 | Mar 2005 → Jul 2006 | diabetic retinopathy | University of Sao Paulo | Completed | No outcome recorded |
| Phase 2/3 | NCT00148551 | Jan 2004 → Mar 2008 | age-related macular degeneration | Canadian Retinal Trials Group | Unknown | No outcome recorded |
| Phase 2/3 | NCT00305630 | Jul 2002 → Nov 2005 | age-related macular degeneration, choroidal neovascularization | Johns Hopkins University | Completed | No outcome recorded |
| Phase 329 trials | ||||||
| Phase 3 | NCT07189572 | Oct 2025 → Aug 2027 expected | otitis media with effusion | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06524323 | Sep 2024 → Aug 2026 overdue | prurigo nodularis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06269705 | Feb 2024 → Dec 2026 expected | osteoarthritis | Pacira Pharmaceuticals, Inc | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06605911 | Jun → Aug 2023 | lichen planus, oral | Shaymaa Hussein Rafat Kotb | Completed | No outcome recorded |
| Phase 3 | NCT04468542 | Jan 2021 → Dec 2022 | — | University of South Florida | Unknown | No outcome recorded |
| Phase 3 | NCT04347733 | May 2017 → Mar 2019 | frozen shoulder | Veterans Health Service Medical Center, Seoul, Korea | Completed | No outcome recorded |
| Phase 3 | NCT03097315 | Apr 2017 → Jan 2018 | anterior uveitis, intermediate uveitis, panuveitis, posterior uveitis | Clearside Biomedical, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT03046446 | Feb 2017 → Jul 2018 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02447185 | Jun 2015 → Dec 2020 | proliferative diabetic retinopathy | JUNYAN ZHANG | Unknown | No outcome recorded |
| Phase 3 | NCT02357459 | Jan 2015 → Jan 2016 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 3 | NCT02873026 | Oct 2014 → Mar 2020 | — | Moorfields Eye Hospital NHS Foundation Trust | Completed | No outcome recorded |
| Phase 3 | NCT01447160 | Oct 2011 → Apr 2012 | — | Federal University of São Paulo | Unknown | No outcome recorded |
| Phase 3 | NCT01572350 | Oct 2010 → Dec 2013 | diabetic macular edema | Hospital Universitario de Canarias | Completed | No outcome recorded |
| Phase 3 | NCT01095809 | Apr 2010 → Apr 2013 | uveitis | Hospital Clinic of Barcelona | Terminated | No outcome recorded |
| Phase 3 | NCT00600301 | Jan 2008 | diabetic macular edema | Asociación para Evitar la Ceguera en México | Withdrawn | No outcome recorded |
| Phase 3 | NCT00565019 | Nov 2007 → Aug 2011 | palmar fibromatosis | Sunnybrook Health Sciences Centre | Completed | No outcome recorded |
| Phase 3 | NCT00532415 | Sep 2007 | — | Alcon Research | Completed | No outcome recorded |
| Phase 3 | NCT00444600 | Mar 2007 → Dec 2009 | diabetic macular edema | Jaeb Center for Health Research | Completed | No outcome recorded |
| Phase 3 | NCT00370539 | Sep → Nov 2006 | wet macular degeneration | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT00309192 | Apr 2006 → Jul 2009 | diabetic macular edema, type 2 diabetes mellitus | Institute of Applied Ophthalmobiology - IOBA | Completed | No outcome recorded |
| Phase 3 | NCT00344942 | Apr 2006 → Apr 2007 | rhinitis | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00370669 | Nov 2005 → Feb 2007 | diabetic macular edema | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT00242580 | Sep 2005 → Jan 2008 | age-related macular degeneration, choroidal neovascularization | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00105404 | Mar 2005 → Oct 2006 | diabetic macular edema | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 3 | NCT00106132 | Mar → Nov 2005 | cystoid macular edema, retinal vein occlusion | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 3 | NCT00100009 | Dec 2004 → Dec 2006 | macular degeneration | National Eye Institute (NEI) | Completed | No outcome recorded |
| Phase 3 | NCT00367133 | Jul 2004 → May 2008 | diabetic macular edema | Jaeb Center for Health Research | Completed | No outcome recorded |
| Phase 3 | NCT00132925 | Nov 2003 → Feb 2006 | perennial allergic rhinitis | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00373282 | Jun 2001 → Jun 2003 | proliferative vitreoretinopathy | Shahid Beheshti University of Medical Sciences | Completed | No outcome recorded |
| Phase 439 trials | ||||||
| Phase 4 | NCT06935877 | Apr 2025 → Jun 2026 overdue | bursitis | Shin Kong Wu Ho-Su Memorial Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06897969 | Apr → Sep 2025 overdue | keloid | Nishtar Medical University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06801587 | Feb → May 2025 | — | Fang Luo | Completed | No outcome recorded |
| Phase 4 | NCT06782529 | Jan 2025 → Jan 2027 expected | osteoarthritis, knee | Mayo Clinic | Recruiting | No outcome recorded |
| Phase 4 | NCT06779396 | Jan → Mar 2025 overdue | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07006168 | Nov 2024 → Dec 2026 expected | — | The University of Hong Kong | Recruiting | No outcome recorded |
| Phase 4 | NCT04895280 | Nov 2024 → Nov 2026 | rotator cuff syndrome, tendinitis | Michael Khazzam | Withdrawn | No outcome recorded |
| Phase 4 | NCT06362005 | May 2024 → Jul 2025 | lichen planus, oral | Al-Azhar University | Completed | No outcome recorded |
| Phase 4 | NCT05806021 | Jan 2024 → Dec 2025 overdue | osteoarthritis, knee | University of Montreal Hospital Centre (CHUM) | Recruiting | No outcome recorded |
| Phase 4 | NCT06084364 | Nov 2023 → Jan 2027 expected | osteoarthritis, hand | Diakonhjemmet Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT06069804 | Oct → Dec 2023 | — | Beijing Tiantan Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05178485 | Jul 2023 → Dec 2024 | — | University of Texas Southwestern Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT06882551 | Apr → Nov 2023 | diabetic macular edema | Khyber Teaching Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04075136 | Mar 2023 → Nov 2024 | wet macular degeneration | Wake Forest University Health Sciences | Withdrawn | No outcome recorded |
| Phase 4 | NCT05436535 | Nov 2022 → Apr 2025 | atopic eczema | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 4 | NCT05336968 | Sep 2022 → Nov 2025 | osteoarthritis, knee | United Health Services Hospitals, Inc. | Unknown | No outcome recorded |
| Phase 4 | NCT05292677 | Jul 2021 → Jun 2023 | laryngeal disorder | Eastern Virginia Medical School | Unknown | No outcome recorded |
| Phase 4 | NCT04641351 | May 2021 → Aug 2026 overdue | osteoarthritis, knee, synovitis | The Cleveland Clinic | Active not recruiting | No outcome recorded |
| Phase 4 | NCT04786210 | Jan 2021 → Dec 2022 | keloid | NYU Langone Health | Completed | No outcome recorded |
| Phase 4 | NCT03991936 | Mar 2020 → Mar 2023 | nail disorder, psoriasis | Weill Medical College of Cornell University | Completed | No outcome recorded |
| Phase 4 | NCT04701593 | Jan 2020 → Oct 2022 | retinal detachment | Virginia Polytechnic Institute and State University | Completed | No outcome recorded |
| Phase 4 | NCT04228029 | Aug 2019 → Feb 2020 | alopecia areata | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT04003376 | Jul 2019 → Jul 2021 | alopecia areata | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT03914092 | Jun 2019 → Aug 2022 | — | Assiut University | Completed | No outcome recorded |
| Phase 4 | NCT05139667 | May 2019 → Oct 2021 | lichen planus, oral | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT03995641 | Feb 2019 → Sep 2023 | pelvic organ prolapse | Kettering Health Network | Withdrawn | No outcome recorded |
| Phase 4 | NCT04498260 | Jan 2019 → Mar 2021 | — | Cancer Institute of the State of São Paulo | Unknown | No outcome recorded |
| Phase 4 | NCT03640650 | Aug 2018 → Mar 2021 | cataract | PeriPharm | Terminated | No outcome recorded |
| Phase 4 | NCT03895840 | Mar 2018 → May 2021 | osteoarthritis, knee | University of Kansas Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03291197 | Oct 2017 → Oct 2018 | complex regional pain syndrome | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT03105674 | May → Nov 2017 | anal fistula, hemorrhoid, ulcer of anus and rectum | Columbia University | Withdrawn | No outcome recorded |
| Phase 4 | NCT04115644 | May → Sep 2017 | rotator cuff syndrome | Michael Khazzam | Terminated | No outcome recorded |
| Phase 4 | NCT02806752 | Jan 2017 → Dec 2018 | wet macular degeneration | Aier School of Ophthalmology, Central South University | Unknown | No outcome recorded |
| Phase 4 | NCT02858297 | May 2015 → Jun 2016 | lichen planus, oral | Ain Shams University | Completed | No outcome recorded |
| Phase 4 | NCT01238536 | Apr 2011 → Aug 2013 | spinal stenosis | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT01230424 | Mar 2011 → Jan 2015 | osteoarthritis, knee | Tufts Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01154153 | Jun → Oct 2010 | allergic rhinitis | Sanofi | Completed | No outcome recorded |
| Phase 4 | NCT00779792 | Sep → Nov 2008 | occupational dermatitis | Odense University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00554476 | Jan 2003 → Apr 2006 | epicondylitis | Azad University of Medical Sciences | Terminated | No outcome recorded |
| Phase not applicable37 trials | ||||||
| — | NCT07660120 | Jul 2026 → Jul 2027 expected | reactive cutaneous fibrous lesion | University of California, Davis | Not yet recruiting | No outcome recorded |
| — | NCT07201766 | Dec 2025 → Feb 2026 overdue | keloid | King Edward Medical University | Not yet recruiting | No outcome recorded |
| — | NCT07409571 | Oct 2025 → May 2026 overdue | gingival recession | Kahramanmaras Sutcu Imam University | Recruiting | No outcome recorded |
| — | NCT07042282 | Aug 2025 → Aug 2027 expected | carpal tunnel syndrome, rheumatic disorder | Yun Qian | Not yet recruiting | No outcome recorded |
| — | NCT06761768 | Aug 2025 → Jul 2026 overdue | arthritis, sacroiliac | Tri-Service General Hospital (TSGH) | Not yet recruiting | No outcome recorded |
| — | NCT07043179 | Jul 2025 → Jul 2027 expected | carpal tunnel syndrome | Yun Qian | Not yet recruiting | No outcome recorded |
| — | NCT07420166 | Jan → Jun 2025 | keloid | Muhammad Aamir Latif | Completed | No outcome recorded |
| — | NCT06407180 | Jul 2024 → Dec 2026 expected | — | Teeradon Waewworawit | Not yet recruiting | No outcome recorded |
| — | NCT07471997 | Jun 2024 → Feb 2025 | disease of orbital part of eye adnexa | Instituto de Oftalmología Fundación Conde de Valenciana | Completed | No outcome recorded |
| — | NCT06327581 | Dec 2023 → Dec 2026 expected | alopecia areata | Zagazig University | Recruiting | No outcome recorded |
| — | NCT06088147 | Dec 2023 → Mar 2024 | alopecia areata | Al-Azhar University | Unknown | No outcome recorded |
| — | NCT06798025 | Jul 2023 → Jun 2024 | stenosis of lacrimal punctum | Tanta University | Completed | No outcome recorded |
| — | NCT07567118 | May 2023 → Jan 2025 | cataract | Damascus University | Completed | No outcome recorded |
| — | NCT04574232 | Jan 2023 → Dec 2024 | — | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| — | NCT05165875 | Jun 2022 → Feb 2024 | de Quervain disease | National University Hospital, Singapore | Unknown | No outcome recorded |
| — | NCT04959721 | Jul → Sep 2021 | — | Min Cheol Chang | Unknown | No outcome recorded |
| — | NCT05345808 | Mar 2021 → Feb 2022 | retinal vein occlusion | Al-Azhar University | Completed | No outcome recorded |
| — | NCT04812626 | Jan → Aug 2021 | keloid | B.P. Koirala Institute of Health Sciences | Completed | No outcome recorded |
| — | NCT05428683 | Dec 2020 → Aug 2021 | — | Emad Abdel Aal Saliem | Completed | No outcome recorded |
| — | NCT04627402 | Nov 2020 → Jun 2021 | diabetic macular edema, type 2 diabetes mellitus | Zhongshan Ophthalmic Center, Sun Yat-sen University | Unknown | No outcome recorded |
| — | NCT04364425 | May 2020 → Sep 2021 | frozen shoulder | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT05038072 | Jul 2019 → Nov 2020 | macular retinal edema, retinal vein occlusion | Damascus University | Completed | No outcome recorded |
| — | NCT04812977 | Jun → Dec 2018 | central retinal vein occlusion with macular edema | Hayatabad Medical Complex | Completed | No outcome recorded |
| — | NCT03431961 | Mar 2018 → Feb 2019 | allergic asthma | Gail Gauvreau | Unknown | No outcome recorded |
| — | NCT03622853 | Jan 2018 → Mar 2019 | frozen shoulder | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT03365141 | Nov 2017 → Sep 2018 | vitiligo | The Catholic University of Korea | Unknown | No outcome recorded |
| — | NCT03072290 | Feb 2017 → Nov 2018 | carpal tunnel syndrome | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| — | NCT02939482 | Oct 2016 → Aug 2018 | radiculopathy, spinal stenosis, spondylosis | Navamindradhiraj University | Completed | No outcome recorded |
| — | NCT02781818 | Jun 2016 → Jun 2017 | hidradenitis suppurativa | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| — | NCT02996097 | Apr 2016 → Jun 2018 | keloid | Johns Hopkins University | Completed | No outcome recorded |
| — | NCT02457026 | Jan 2016 → Jan 2018 | wet macular degeneration | Duke University | Withdrawn | No outcome recorded |
| — | NCT03132051 | Apr 2013 → Feb 2018 | carpal tunnel syndrome | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT01736670 | Apr → May 2012 | — | Patel, Rita Vikram, M.D. | Completed | No outcome recorded |
| — | NCT00924508 | Jul 2008 → Sep 2011 | dermatitis | University of California, San Francisco | Terminated | No outcome recorded |
| — | NCT00789971 | Mar 2007 → Mar 2008 | eye adnexa disorder | Sligo General Hospital | Completed | No outcome recorded |
| — | NCT00447031 | Mar → Nov 2007 | macular degeneration | Yonsei University | Withdrawn | No outcome recorded |
| — | NCT00238563 | — | glaucoma | Stanford University | Withdrawn | No outcome recorded |
Also used as a comparator or background therapy in 221 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 05 trials | ||||||
| Phase 0 | NCT04645303 Comparator | Nov 2020 → Apr 2021 | arthropathy | Dubai Health Authority | Unknown | No outcome recorded |
| Phase 0 | NCT04336488 Comparator | Jan → Jun 2020 | oral erosive lichen | Jaylane kadry Ghonima | Unknown | No outcome recorded |
| Phase 0 | NCT03415165 Comparator | Jan 2018 → Jan 2019 | lichen planus, oral | Cairo University | Unknown | No outcome recorded |
| Phase 0 | NCT02031367 Comparator | Mar 2014 → Dec 2016 | pes anserinus tendinitis or bursitis | C.R.Darnall Army Medical Center | Unknown | No outcome recorded |
| Phase 0 | NCT01382771 Comparator | Oct 2010 → Sep 2012 | — | University of Florida | Completed | No outcome recorded |
| Phase 16 trials | ||||||
| Phase 1 | NCT03758365 Comparator | Nov 2018 | vascular disorder | MC2 Therapeutics | Completed | No outcome recorded |
| Phase 1 | NCT03180125 Comparator | Aug → Oct 2017 | carpal tunnel syndrome | Assiut University | Completed | No outcome recorded |
| Phase 1 | NCT04126720 Comparator | Jan 2016 → Apr 2017 | lichen planus, oral | Cairo University | Completed | No outcome recorded |
| Phase 1 | NCT02294656 Comparator | Nov 2014 → Sep 2018 | cystoid macular edema | Soll Eye | Completed | No outcome recorded |
| Phase 1 | NCT01978301 Comparator | Apr 2014 → Feb 2015 | — | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 1 | NCT01688362 Comparator | Nov 2012 → May 2014 | rotator cuff syndrome | University of North Carolina, Chapel Hill | Terminated | No outcome recorded |
| Phase 1/28 trials | ||||||
| Phase 1/2 | NCT06810752 Comparator | Oct 2024 → Feb 2025 overdue | lichen planus, oral | British University In Egypt | Enrolling by invitation | No outcome recorded |
| Phase 1/2 | NCT05893108 Comparator | Mar → Sep 2024 | keloid | Yuni Eka Anggraini | Unknown | No outcome recorded |
| Phase 1/2 | NCT07141446 Comparator | Feb 2023 → Feb 2024 | lichen planus, oral | Goa Dental College | Completed | No outcome recorded |
| Phase 1/2 | NCT05657496 Comparator | Dec 2022 → Jun 2025 | osteoarthritis, knee | University of Missouri-Columbia | Terminated | No outcome recorded |
| Phase 1/2 | NCT05288725 Comparator | Aug 2022 → Jun 2024 | osteoarthritis, knee | Next Generation Regenerative Medicine LLC | Unknown | No outcome recorded |
| Phase 1/2 | NCT04660786 Comparator | Nov 2021 → Dec 2022 | alopecia areata | Alexandria University | Unknown | No outcome recorded |
| Phase 1/2 | NCT04863183 Comparator | Jun → Dec 2021 | osteoarthritis, knee | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | Unknown | No outcome recorded |
| Phase 1/2 | NCT02075749 Comparator | May 2013 → Feb 2014 | mucositis | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 237 trials | ||||||
| Phase 2 | NCT07515872 Comparator | May 2026 → May 2027 expected | osteoarthritis, knee | ZetrOZ, Inc. | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06981767 Comparator | Feb → Jul 2026 overdue | lichen planus, oral | Cairo University | Recruiting | No outcome recorded |
| Phase 2 | NCT06401317 Comparator | Nov 2025 → Dec 2027 expected | osteoarthritis, hand | University of Quebec at Trois-Rivières | Recruiting | No outcome recorded |
| Phase 2 | NCT06977568 Comparator | Jul → Oct 2025 | osteoarthritis, hip | Pacira Pharmaceuticals, Inc | Terminated | No outcome recorded |
| Phase 2 | NCT06993337 Comparator | Jun 2025 → May 2026 overdue | aphthous stomatitis | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06965088 Comparator | Apr 2025 → Jun 2026 overdue | keloid formation | Ramathibodi Hospital | Active not recruiting | No outcome recorded |
| Phase 2 | NCT06748404 Comparator | Mar 2025 → Dec 2027 expected | — | University of California, San Diego | Recruiting | No outcome recorded |
| Phase 2 | NCT06622213 Comparator | Oct 2024 → May 2025 overdue | aphthous stomatitis | Khon Kaen University | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT06814288 Comparator | May 2024 → Feb 2025 overdue | keloid | Padjadjaran University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05005000 Comparator | May 2022 → May 2023 | arthritic joint disease | NYU Langone Health | Withdrawn | No outcome recorded |
| Phase 2 | NCT05190770 Background | Dec 2021 → Aug 2024 | breast cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT04885972 Comparator | Nov 2021 → Sep 2023 | osteoarthritis, knee | Sorrento Therapeutics, Inc. | Unknown | No outcome recorded |
| Phase 2 | NCT04994951 Comparator | Sep 2021 → Jul 2023 | psoriasis | The First Affiliated Hospital of Zhejiang Chinese Medical University | Unknown | No outcome recorded |
| Phase 2 | NCT05134181 Comparator | Aug 2021 → Aug 2022 | arthritis, sacroiliac | Mansoura University | Unknown | No outcome recorded |
| Phase 2 | NCT04391621 Comparator | May → Dec 2021 | keloid | Makerere University | Unknown | No outcome recorded |
| Phase 2 | NCT04976673 Comparator | Dec 2020 → Jan 2021 | lichen planus, oral | Wroclaw Medical University | Completed | No outcome recorded |
| Phase 2 | NCT05429450 Comparator | Jul 2020 → Jul 2022 | endocrine exophthalmos | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT04991012 Comparator | Feb 2020 → Mar 2021 | lichen planus, oral | Wroclaw Medical University | Completed | No outcome recorded |
| Phase 2 | NCT04216017 Comparator | Jan 2020 → Apr 2022 | — | University of Washington | Completed | No outcome recorded |
| Phase 2 | NCT03293368 Comparator | Jan 2018 → Jan 2021 | oral erosive lichen | Cairo University | Completed | No outcome recorded |
| Phase 2 | NCT02870738 Comparator | Apr 2017 → Feb 2026 overdue | interstitial cystitis | Corewell Health East | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03002974 Comparator | Dec 2016 → Jun 2018 | gout | Swedish Orphan Biovitrum | Completed | No outcome recorded |
| Phase 2 | NCT02468583 Comparator | Feb 2015 → Jul 2016 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Terminated | No outcome recorded |
| Phase 2 | NCT02453503 Comparator | Jan 2014 → Mar 2015 | lichen planus, oral | Isfahan University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT02003365 Comparator | Nov 2013 → Apr 2014 | osteoarthritis, knee | Pacira Pharmaceuticals, Inc | Completed | No outcome recorded |
| Phase 2 | NCT01766609 Comparator | Jan 2013 → Oct 2015 | vitiligo | University of British Columbia | Unknown | No outcome recorded |
| Phase 2 | NCT01544283 Comparator | Mar 2012 → Jan 2014 | shoulder impingement syndrome | Injury Care Medical Center | Unknown | No outcome recorded |
| Phase 2 | NCT01473277 Comparator | Jan → Jun 2012 | arthropathy, hemiplegia, stroke disorder | The Foundation Institute San Raffaele G. Giglio of Cefalù | Unknown | No outcome recorded |
| Phase 2 | NCT01249937 Comparator | Jan → Jul 2011 | wet macular degeneration | University Health Network, Toronto | Unknown | No outcome recorded |
| Phase 2 | NCT01044329 Comparator | Jan → Aug 2010 | retinal vein occlusion | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT01178697 Comparator | Jan → Sep 2010 | central retinal vein occlusion | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT07702474 Comparator | Apr → Nov 2009 | aphthous stomatitis, ulcerative stomatitis | Kerman University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT01085279 Comparator | Mar 2009 → Feb 2010 | skin pigmentation disorder | Netherlands Institute for Pigment Disorders | Completed | No outcome recorded |
| Phase 2 | NCT01524744 Comparator | Mar 2009 → Oct 2012 | lichen planus, oral | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT00798369 Comparator | Nov 2008 → Aug 2009 | gout | Novartis | Completed | No outcome recorded |
| Phase 2 | NCT00815360 Comparator | Feb 2008 → Jul 2011 | diabetic macular edema | Retina Associates of Florida, P.A. | Completed | No outcome recorded |
| Phase 2 | NCT00506896 Comparator | Jul 2004 → Jan 2006 | rheumatoid arthritis | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 2/39 trials | ||||||
| Phase 2/3 | NCT07151417 Comparator | Sep 2025 → Aug 2026 overdue | osteoarthritis, knee | Walter Reed National Military Medical Center | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT06910579 Comparator | Mar 2025 → Jan 2026 overdue | aphthous stomatitis | British University In Egypt | Recruiting | No outcome recorded |
| Phase 2/3 | NCT05031143 Comparator | Apr 2020 → Feb 2021 | Vogt-Koyanagi-Harada disease | Benha University | Completed | No outcome recorded |
| Phase 2/3 | NCT04434105 Comparator | Feb → Nov 2020 | carpal tunnel syndrome | Tanta University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03413059 Comparator | Feb → Jul 2018 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT03131882 Comparator | Oct 2016 → Jun 2017 | trigger thumb | Mahidol University | Unknown | No outcome recorded |
| Phase 2/3 | NCT02870673 Comparator | Aug 2016 → Aug 2017 | carpal tunnel syndrome | Taipei Medical University Hospital | Unknown | No outcome recorded |
| Phase 2/3 | NCT02985619 Comparator | Jul 2016 → Apr 2017 | diabetic macular edema | University of Sao Paulo | Completed | No outcome recorded |
| Phase 2/3 | NCT00811200 Comparator | Sep 2009 → Jan 2012 | uveal melanoma | Leiden University Medical Center | Unknown | No outcome recorded |
| Phase 332 trials | ||||||
| Phase 3 | NCT06729840 Comparator | Dec 2024 → Apr 2025 overdue | keloid formation | Sohag University | Recruiting | No outcome recorded |
| Phase 3 | NCT07311759 Comparator | Aug 2024 → Dec 2025 overdue | paronychia | Cairo University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT06135259 Comparator | May → Jul 2024 | lichen planus, oral | Ain Shams University | Unknown | No outcome recorded |
| Phase 3 | NCT05764304 Comparator | Feb 2023 → Feb 2025 | osteoarthritis, knee | Shanghai 6th People's Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT05658874 Background | Dec 2022 → Dec 2024 | interstitial cystitis, levator syndrome | Jocelyn Fitzgerald | Terminated | No outcome recorded |
| Phase 3 | NCT05648032 Comparator | Oct 2022 → Apr 2025 | epicondylitis, rotator cuff syndrome | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT05160441 Comparator | Sep 2022 → May 2025 | osteoarthritis | Walter Reed National Military Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT05158699 Comparator | Oct 2021 → Aug 2024 | cataract, cystoid macular edema | Luigi Rondas | Terminated | No outcome recorded |
| Phase 3 | NCT03463915 Comparator | Jan 2019 → Oct 2020 | interstitial cystitis | Olivia Cardenas-Trowers, M.D. | Completed | No outcome recorded |
| Phase 3 | NCT03568318 Background | Aug 2018 → Feb 2021 overdue | atopic eczema | AbbVie | Active not recruiting | No outcome recorded |
| Phase 3 | NCT02828163 Comparator | Jan → Oct 2016 | pemphigus vulgaris | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT02374060 Comparator | Jun 2015 → Aug 2017 | macular retinal edema, uveitis | JHSPH Center for Clinical Trials | Completed | No outcome recorded |
| Phase 3 | NCT02329288 Comparator | May → Dec 2015 | non-arteritic anterior ischemic optic neuropathy | Second Military Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT02519738 Comparator | Jan 2015 → Nov 2018 | — | University of Michigan | Terminated | No outcome recorded |
| Phase 3 | NCT02022930 Comparator | Jan 2014 → Dec 2015 | osteoarthritis, knee | Carbylan Therapeutics, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT02025023 Comparator | Dec 2013 → Jul 2025 overdue | chalazion | University of Washington | Recruiting | No outcome recorded |
| Phase 3 | NCT01774474 Comparator | Jul 2013 → Nov 2016 | cataract, cystoid macular edema, diabetes mellitus | Maastricht University Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT02329600 Background | Jun 2013 → Aug 2014 | lichen planus, oral | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT02767635 Comparator | Jan 2012 → Dec 2016 | epicondylitis | National Cheng-Kung University Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT01470989 Background | Nov 2011 → May 2013 | gout | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01362608 Comparator | Jun 2011 → May 2015 | gout | Novartis Pharmaceuticals | Terminated | No outcome recorded |
| Phase 3 | NCT01356602 Comparator | May 2011 → Sep 2012 | gout | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01073995 Comparator | Mar 2010 → Nov 2015 | radiculopathy | Horizon Health Network | Completed | No outcome recorded |
| Phase 3 | NCT01080131 Comparator | Mar → Nov 2010 | gout | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT01570985 Comparator | Feb 2010 → Dec 2013 | frozen shoulder | Satya Pal Sharma | Unknown | No outcome recorded |
| Phase 3 | NCT01029652 Comparator | Dec 2009 → Oct 2010 | gout | Novartis Pharmaceuticals | Completed | No outcome recorded |
| Phase 3 | NCT00665977 Comparator | Sep 2007 → Jul 2010 | nasal cavity disorder, obstructive sleep apnea syndrome, sinusitis | Clayton Sleep Insititute | Completed | No outcome recorded |
| Phase 3 | NCT00445003 Comparator | Mar 2007 → Oct 2009 | diabetic macular edema, proliferative diabetic retinopathy | Jaeb Center for Health Research | Completed | No outcome recorded |
| Phase 3 | NCT00370370 Comparator | Nov 2005 → ? | wet macular degeneration | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT00279916 Comparator | Sep 2005 → Feb 2009 | otitis media with effusion, rhinitis, serous otitis media | Mayo Clinic | Completed | No outcome recorded |
| Phase 3 | NCT00764244 Comparator | Jan 2005 → Dec 2009 | diabetes mellitus, diabetic macular edema | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT00105027 Comparator | Oct 2004 → Feb 2009 | cystoid macular edema, retinal vein occlusion | The Emmes Company, LLC | Completed | No outcome recorded |
| Phase 456 trials | ||||||
| Phase 4 | NCT07666620 Comparator | Oct 2026 → Apr 2027 expected | hypertrophic lichen planus | Noor Aziz | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07453238 Comparator | Apr → Oct 2026 expected | alopecia areata | Hayat Abad Medical Complex, Peshawar | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07672730 Comparator | Feb → Apr 2026 | aphthous stomatitis | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT07100145 Comparator | Jan 2026 → Sep 2027 expected | lichen planus, oral | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07544576 Comparator | Dec 2025 → Dec 2026 expected | osteoarthritis, knee | Sosi Dzhugarian | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT07283874 Comparator | Dec 2025 → Dec 2026 expected | carpal tunnel syndrome | Assiut University | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06578728 Comparator | Sep 2025 → Jun 2026 | psoriasis | Weill Medical College of Cornell University | Terminated | No outcome recorded |
| Phase 4 | NCT06478186 Comparator | Aug 2024 → Dec 2026 expected | osteoarthritis, knee, type 2 diabetes mellitus | University of Kansas Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT06793982 Comparator | Feb 2024 → Dec 2025 overdue | osteoarthritis, hip | LifeBridge Health | Recruiting | No outcome recorded |
| Phase 4 | NCT06279507 Comparator | Feb 2024 → Jan 2025 | osteoarthritis, knee | Phramongkutklao College of Medicine and Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT07014280 Comparator | Sep 2023 → Sep 2024 overdue | keloid | Kasr El Aini Hospital | Active not recruiting | No outcome recorded |
| Phase 4 | NCT05882864 Comparator | Aug 2023 → Jun 2025 | lichen planus, oral | Ain Shams University | Unknown | No outcome recorded |
| Phase 4 | NCT05844618 Comparator | May 2023 → Nov 2024 | atopic eczema | Innovaderm Research Inc. | Completed | No outcome recorded |
| Phase 4 | NCT07114016 Comparator | May 2023 → May 2025 | lichen planus, oral | Future University in Egypt | Completed | No outcome recorded |
| Phase 4 | NCT05492851 Comparator | Aug 2022 → Jan 2023 | osteoarthritis, knee | Ohio State University | Terminated | No outcome recorded |
| Phase 4 | NCT05331664 Comparator | Jul 2022 → Jul 2026 overdue | rhegmatogenous retinal detachment | Massachusetts Eye and Ear Infirmary | Recruiting | No outcome recorded |
| Phase 4 | NCT05157113 Comparator | May 2022 → Jun 2026 overdue | cataract | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 4 | NCT05139875 Comparator | Jan 2022 → Apr 2024 | osteoarthritis, knee | Thammasat University | Completed | No outcome recorded |
| Phase 4 | NCT05887804 Comparator | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
| Phase 4 | NCT05939817 Comparator | Oct 2021 → Jun 2022 | keloid | Rumah Sakit Pusat Angkatan Darat Gatot Soebroto | Completed | No outcome recorded |
| Phase 4 | NCT05161468 Comparator | Aug 2021 → May 2025 | — | Brooke Army Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT04731233 Comparator | Mar 2021 → Feb 2024 | osteoarthritis, temporomandibular joint disorder | University of Florida | Terminated | No outcome recorded |
| Phase 4 | NCT05058209 Comparator | Nov 2020 → Apr 2021 | osteoarthritis, knee | ROC Foundation | Completed | No outcome recorded |
| Phase 4 | NCT02917564 Comparator | Oct 2020 → May 2023 | glaucoma, optic choroid disorder | Sunnybrook Health Sciences Centre | Unknown | No outcome recorded |
| Phase 4 | NCT04412148 Comparator | Jan → Jul 2020 | alopecia areata | Kasr El Aini Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05438277 Comparator | Jan 2020 → Aug 2022 | arthropathy | Campbell Clinic | Completed | No outcome recorded |
| Phase 4 | NCT03636373 Comparator | Oct 2019 → Aug 2021 | gout | Rutgers, The State University of New Jersey | Terminated | No outcome recorded |
| Phase 4 | NCT04117893 Background | Oct 2019 → Jun 2021 | chronic pain syndrome, osteoarthritis, knee | Beijing Tiantan Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04002037 Comparator | Jun 2019 → May 2022 | — | University of Missouri-Columbia | Terminated | No outcome recorded |
| Phase 4 | NCT03473600 Comparator | Nov 2018 → Jul 2019 | alopecia areata | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT03630198 Comparator | Oct 2018 → Sep 2019 | acne, alopecia areata, epidermoid cysts, frontal fibrosing alopecia +10 | Vanderbilt University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03319784 Comparator | Sep 2018 → Sep 2020 | diabetes mellitus, rotator cuff syndrome, tendinitis | Milton S. Hershey Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT04207931 Comparator | Apr 2018 → Nov 2026 expected | central centrifugal cicatricial alopecia | Wake Forest University Health Sciences | Recruiting | No outcome recorded |
| Phase 4 | NCT03382925 Comparator | Dec 2017 → Aug 2019 | radiculopathy | University of Utah | Terminated | No outcome recorded |
| Phase 4 | NCT03245671 Comparator | Dec 2017 → Apr 2019 | lumbar spinal stenosis | Hospital for Special Surgery, New York | Withdrawn | No outcome recorded |
| Phase 4 | NCT03166761 Comparator | Sep 2017 → Feb 2023 | arthritis, sacroiliac | Vanderbilt University Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT06209957 Comparator | Jun 2017 → Jan 2019 | carpal tunnel syndrome | Menoufia University | Completed | No outcome recorded |
| Phase 4 | NCT03572959 Comparator | Dec 2016 → Mar 2017 | lichen planus, oral | Sherine Adel Nasry | Completed | No outcome recorded |
| Phase 4 | NCT03634852 Comparator | Oct 2016 → Feb 2018 | endophthalmitis | Suzan A Rattan | Completed | No outcome recorded |
| Phase 4 | NCT02920177 Comparator | Aug 2016 → Aug 2018 | — | University of Michigan | Terminated | No outcome recorded |
| Phase 4 | NCT02877485 Comparator | Aug 2016 → Aug 2019 | nasal disorder | Stanford University | Completed | No outcome recorded |
| Phase 4 | NCT03535233 Comparator | Mar 2016 → Jun 2017 | alopecia areata | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT02592629 Comparator | Feb 2016 → Jun 2017 | — | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT02618603 Comparator | Feb 2016 → Jun 2018 | stroke disorder | Sir Run Run Shaw Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02598869 Comparator | Nov 2015 → May 2016 | cystoid macular edema, uveitis | Oregon Health and Science University | Withdrawn | No outcome recorded |
| Phase 4 | NCT02819908 Comparator | Sep 2015 → Apr 2016 | uveal disorder | Eye Center of North Florida | Completed | No outcome recorded |
| Phase 4 | NCT02613455 Comparator | Jul 2015 → Dec 2016 | epicondylitis | Walter Reed National Military Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03120923 Background | Jan 2015 → Aug 2016 | shoulder impingement syndrome | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02379000 Comparator | Jan 2015 → Dec 2017 | retinal detachment, uveal melanoma | Charite University, Berlin, Germany | Unknown | No outcome recorded |
| Phase 4 | NCT02515045 Comparator | Jan 2015 → Mar 2016 | cataract | Carolina Eyecare Physicians, LLC | Completed | No outcome recorded |
| Phase 4 | NCT02120261 Comparator | May 2014 → Nov 2016 | myofascial pain syndrome | The University of Texas Health Science Center, Houston | Terminated | No outcome recorded |
| Phase 4 | NCT02022722 Comparator | Aug 2013 → Apr 2014 | — | University of Cincinnati | Unknown | No outcome recorded |
| Phase 4 | NCT01652495 Comparator | Mar 2012 → May 2013 | adrenocortical insufficiency, calcific tendinitis | Rizzoli Orthopaedic Institute | Completed | No outcome recorded |
| Phase 4 | NCT01045694 Comparator | Mar 2011 → Aug 2012 | polyarticular arthritis | University of Missouri-Columbia | Terminated | No outcome recorded |
| Phase 4 | NCT01874574 Comparator | Jan 2011 → Jun 2013 | osteoarthritis, knee | Thammasat University | Completed | No outcome recorded |
| Phase 4 | NCT00449072 Comparator | Mar 2007 → Oct 2011 | perennial allergic rhinitis | Sanofi | Completed | No outcome recorded |
| Phase not applicable68 trials | ||||||
| — | NCT07606391 Comparator | Aug 2026 overdue | reactive cutaneous fibrous lesion | Sohag University | Not yet recruiting | No outcome recorded |
| — | NCT07277998 Comparator | Mar → Jul 2026 overdue | oral submucous fibrosis | Karachi Medical and Dental College | Not yet recruiting | No outcome recorded |
| — | NCT07120204 Comparator | Aug 2025 → Aug 2026 overdue | chronic pain syndrome, plantar fasciitis | TC Erciyes University | Not yet recruiting | No outcome recorded |
| — | NCT07565844 Comparator | Feb 2025 → Aug 2026 overdue | postherpetic neuralgia | Zagazig University | Recruiting | No outcome recorded |
| — | NCT06839313 Comparator | Feb → Aug 2025 | aphthous stomatitis | Batman University | Completed | No outcome recorded |
| — | NCT06712290 Comparator | Nov 2024 → Dec 2025 | rotator cuff syndrome | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Withdrawn | No outcome recorded |
| — | NCT07194135 Comparator | Nov 2024 → Apr 2025 | osteoarthritis, knee | Benha University | Completed | No outcome recorded |
| — | NCT06176248 Comparator | Oct 2024 → Jan 2027 expected | frozen shoulder | Reims University Hospital | Recruiting | No outcome recorded |
| — | NCT06641206 Comparator | Sep 2024 → Jan 2025 overdue | osteoarthritis, knee | Tanta University | Recruiting | No outcome recorded |
| — | NCT07475689 Background | Aug 2024 → Aug 2025 | — | University of Health Sciences Gulhane Faculty of Medicine | Completed | No outcome recorded |
| — | NCT06482398 Comparator | Jul 2024 → Jun 2025 | psoriasis | Chulalongkorn University | Unknown | No outcome recorded |
| — | NCT06453603 Comparator | Jul 2024 → Dec 2026 expected | pes anserinus tendinitis or bursitis | Ramathibodi Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06456099 Background | Jun → Sep 2024 | pes anserinus tendinitis or bursitis | Aalborg University | Unknown | No outcome recorded |
| — | NCT05668286 Comparator | May → Nov 2024 | frozen shoulder | Kartal City Hospital | Unknown | No outcome recorded |
| — | NCT06421038 Comparator | May 2024 | aphthous stomatitis | British University In Egypt | Unknown | No outcome recorded |
| — | NCT06533033 Comparator | Jan → Jul 2024 overdue | lichen planus, oral | Hams Hamed Abdelrahman | Active not recruiting | No outcome recorded |
| — | NCT06220643 Background | Jan → Dec 2024 | bursitis | Taipei Medical University Shuang Ho Hospital | Completed | No outcome recorded |
| — | NCT06165939 Background | Jan → Dec 2024 | frozen shoulder | Tri-Service General Hospital (TSGH) | Unknown | No outcome recorded |
| — | NCT06202963 Comparator | Dec 2023 → Mar 2025 | frozen shoulder | Haydarpasa Numune Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05861570 Background | May 2023 → Apr 2024 | frozen shoulder | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT07263100 Comparator | May 2023 → Jan 2024 | keloid | Somdech Phra Nangchao Sirikit Hospital | Completed | No outcome recorded |
| — | NCT07683429 Comparator | Mar 2023 → Apr 2025 | de Quervain disease | Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi | Completed | No outcome recorded |
| — | NCT06969495 Comparator | Feb → Nov 2023 | aphthous stomatitis | Mahsa University | Completed | No outcome recorded |
| — | NCT05909462 Background | Jan → Apr 2023 | frozen shoulder | Hitit University | Completed | No outcome recorded |
| — | NCT06042010 Comparator | Jan → Feb 2023 | lichen planus, oral | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT05787925 Background | Oct 2022 → Mar 2023 | oral erosive lichen | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT05980572 Background | Sep 2022 → Oct 2023 | frozen shoulder | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| — | NCT05488860 Comparator | Jul 2022 → Jun 2024 | keloid, plantar wart | Xiangya Hospital of Central South University | Unknown | No outcome recorded |
| — | NCT05496530 Comparator | Jul 2022 → Jul 2023 | Vogt-Koyanagi-Harada disease, diabetic macular edema, retinal vein occlusion | Benha University | Unknown | No outcome recorded |
| — | NCT05106192 Background | Apr 2022 → Jun 2025 | anaplastic large cell lymphoma, follicular lymphoma, lymphomatoid papulosis, mycosis fungoides | Case Comprehensive Cancer Center | Withdrawn | No outcome recorded |
| — | NCT05288192 Comparator | Feb → Aug 2022 | cataract, macular retinal edema | Benha University | Unknown | No outcome recorded |
| — | NCT06703970 Comparator | Feb 2022 → Jul 2024 | osteoarthritis, knee | LifeBridge Health | Completed | No outcome recorded |
| — | NCT05951361 Comparator | Feb 2022 → Feb 2023 | oral erosive lichen | Alexandria University | Completed | No outcome recorded |
| — | NCT06332365 Comparator | Jan 2022 → Dec 2023 | lichen planus, oral | Pia Lopez Jornet | Completed | No outcome recorded |
| — | NCT04916353 Comparator | Jun → Nov 2021 | chronic pain syndrome | Taipei Medical University Shuang Ho Hospital | Unknown | No outcome recorded |
| — | NCT04755127 Comparator | Jan 2021 → Dec 2025 | psoriatic arthritis | Maasstad Hospital | Unknown | No outcome recorded |
| — | NCT04176705 Background | Dec 2020 → Sep 2023 | — | Wake Forest University Health Sciences | Completed | No outcome recorded |
| — | NCT04579783 Comparator | Nov 2020 → Oct 2022 | carpal tunnel syndrome | National Taiwan University Hospital | Unknown | No outcome recorded |
| — | NCT04593706 Comparator | Nov 2020 → Oct 2021 | keloid, keloid formation | Tel-Aviv Sourasky Medical Center | Unknown | No outcome recorded |
| — | NCT04346030 Background | Apr 2020 → Jul 2021 | carpal tunnel syndrome | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT06188221 Background | Feb 2020 → Jul 2023 | carpal tunnel syndrome, osteoarthritis, hand | University of Texas at Austin | Completed | No outcome recorded |
| — | NCT05464953 Comparator | Jan 2020 → Apr 2022 | diabetic macular edema | Al-Azhar University | Completed | No outcome recorded |
| — | NCT05385562 Comparator | Jan 2020 → May 2022 | macular retinal edema | Al-Azhar University | Completed | No outcome recorded |
| — | NCT04212949 Background | Nov 2019 → Nov 2020 | radiculopathy | Marmara University | Unknown | No outcome recorded |
| — | NCT02509299 Background | Sep → Nov 2019 | chronic obstructive pulmonary disease | University of Granada | Completed | No outcome recorded |
| — | NCT03771768 Comparator | May 2019 | Behcet disease, autoimmune disease | Cairo University | Unknown | No outcome recorded |
| — | NCT03196310 Comparator | Sep 2018 → Mar 2025 | osteoarthritis, hand | Kettering Health Network | Terminated | No outcome recorded |
| — | NCT04509440 Comparator | May 2018 → Oct 2019 | pes anserinus tendinitis or bursitis | University of Alexandria | Completed | No outcome recorded |
| — | NCT02767492 Comparator | Jan 2017 → Jan 2020 | osteoarthritis, knee | The Hawkins Foundation | Completed | No outcome recorded |
| — | NCT02515318 Comparator | Sep 2015 → Mar 2017 | chronic obstructive pulmonary disease | University of Granada | Unknown | No outcome recorded |
| — | NCT02369068 Comparator | Aug 2015 → Mar 2018 | pelvis syndrome | Jamie Bartley, DO | Completed | No outcome recorded |
| — | NCT02126878 Comparator | Apr 2014 → Jun 2015 | bursitis | West Virginia University | Completed | No outcome recorded |
| — | NCT04833738 Comparator | Sep → Dec 2013 | shoulder impingement syndrome | Şeyhmus KAPLAN | Completed | No outcome recorded |
| — | NCT02708693 Background | Apr 2013 → Apr 2014 | carpal tunnel syndrome | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| — | NCT02295189 Comparator | Jan 2013 → May 2014 | osteoarthritis, knee | San Antonio Military Medical Center | Completed | No outcome recorded |
| — | NCT01950793 Comparator | Nov 2012 → May 2014 | — | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| — | NCT01961752 Comparator | Jul 2012 → Apr 2013 | gastric adenoma, gastric cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT01559584 Comparator | Mar 2012 → Mar 2014 | alopecia areata | Cairo University | Completed | No outcome recorded |
| — | NCT01246284 Comparator | Dec 2010 → Jul 2014 | alopecia areata | University of British Columbia | Completed | No outcome recorded |
| — | NCT01123889 Comparator | May 2010 → May 2011 | rotator cuff syndrome, shoulder impingement syndrome | Loma Linda University | Completed | No outcome recorded |
| — | NCT01800708 Comparator | Jan 2010 → Mar 2013 | cataract | Fundação Altino Ventura | Completed | No outcome recorded |
| — | NCT00999869 Comparator | Nov 2009 → Dec 2012 | alopecia areata | Siriraj Hospital | Unknown | No outcome recorded |
| — | NCT01109446 Comparator | Jan 2009 → Oct 2011 | epicondylitis | University of Aarhus | Completed | No outcome recorded |
| — | NCT02310295 Comparator | Jan 2009 → Dec 2011 | diabetic macular edema | University of Sao Paulo | Completed | No outcome recorded |
| — | NCT00742846 Comparator | Aug 2008 → Dec 2010 | frozen shoulder | Milton S. Hershey Medical Center | Withdrawn | No outcome recorded |
| — | NCT00908817 Comparator | May 2008 → Apr 2009 | — | Soonchunhyang University Hospital | Completed | No outcome recorded |
| — | NCT00229931 Comparator | Nov 2005 → May 2013 | diabetic macular edema | University of Oklahoma | Completed | No outcome recorded |
| — | NCT00746889 Comparator | Mar 2004 → Jul 2008 | osteoarthritis | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 53 cited values
Every value below carries the sentence it was read from. 406 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinolone acetonide | “The intervention was 0.1% triamcinolone acetonide adhesive paste (Kenacort A Orabase - Dermapharm) and 400 mg Vitamin E capsule (Vitamin E 400 - Pharopharmaceuticles) for the...” NCT04126720 ↗356“Local corticosteroid injection in group I: 1 ml of triamcinolone acetonide (40 milligram/1.0 mL) was locally injected in the wrist using a 25-gauge needle, which was slowly...” NCT06209957 ↗ “FX006 is a novel, microsphere-based, extended-release formulation of triamcinolone acetonide for intraarticular (IA) injection designed to maintain treatment concentration in...” PMID 29088579 ↗ Dec 2017 “INTRODUCTION: The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA-ER) in patients with...” PMID 30741382 ↗ Feb 2019 “At the end of surgery, 4mg triamcinolone acetonide and 0.2mg moxifloxacin from 0.5 moxifloxacin preservative-free eye drop) were injected once inferotemporally 3.5 mm posterior...” NCT05428683 ↗ “Patients requiring a corticosteroid injection were prospectively randomized into two cohorts to receive a corticosteroid (triamcinolone acetonide) combined with either...” PMID 33760691 ↗ Apr 2021 “Where patients are treated with topical corticosteroids 1 mg/g Triamcinolone acetonide (Kenacort-A orabase 20 G Pomad: Deva dermatological product,Turkey) applied topically 4...” NCT03415165 ↗ “The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of...” NCT00105027 ↗ “the relative efficacy of the steroids triamcinolone acetonide and clobetasol, the topical immune modulator tacrolimus, a 20% Glycerol ointment compared with an inert ointment...” NCT00779792 ↗ “Recommended TCS include triamcinolone acetonide 0.1% cream or fluocinolone acetonide 0.025% ointment as medium potency topical corticosteroids and hydrocortisone 1% cream as...” NCT03568318 ↗ “Both will underwent median nerve hydro-dissection using 1% lidocain followed by group I injection of Sodium hyaluronate and group II injection of 40 mg of triamcinolone...” NCT03180125 ↗ “This study aimed to compare intravitreous conbercept alone with conbercept plus intravitreous triamcinolone acetonide in DME eyes which showed limited response to anti-VEGF...” NCT04627402 ↗ “Thus, the investigators suppose that pre-emptive scalp infiltration with steroid (triamcinolone acetonide) plus local anesthetic (ropivacaine) could relieve postoperative pain...” NCT06069804 ↗ “Finally, a 24-month, double-blind randomized clinical trial compared the effect of intra-articular sinomenine hydrochloride with that of triamcinolone acetonide in patients...” PMID 41560786 ↗ Dec 2025 “For the steroid injection group, a 1ml injection of a mixture of 0.5ml triamcinolone acetonide (50mg/5ml) and 0.5ml 1% lignoacaine is given intra-thecally into the first...” NCT05165875 ↗ “Generic Name: Triamcinolone acetonide Zilretta is an extended-release synthetic corticosteroid indicated as an intra-articular injection for the management ofosteoarthritis...” NCT05492851 ↗ “5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl...” NCT06703970 ↗ “A phase 3 randomized controlled study comparing triamcinolone acetonide extended-release (TA-ER) to conventional TA crystalline suspension (TAcs) reported variable efficacy results.” PMID 34791634 ↗ Nov 2021 “Subjects in the Experimental Group will received a 2 mL injection consisting of 1 mL of 0.5% bupivacaine (5 mg bupivacaine-HCL) and 1 mL Kenalog-40 (40 mg triamcinolone acetonide).” NCT05178485 ↗ “1 mL of triamcinolone acetonide 40 mg (KENACORT-A IM/Intra-articular Retard 40 mg ampoule) and 1 mL of 2% lidocaine (Aritmal 2% ampoule) will be injected over the plantar fascia.” NCT07120204 ↗ “The study compared the clinical effectiveness of topical Tacrolimus (TAC) in patches or gel with Triamcinolone acetonide (TRI) gel for erosive/atrophic oral lichen planus (OLP)” PMID 36788511 ↗ Feb 2023 “Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria.” NCT02509299 ↗ “Local corticosteroid injection (triamcinolone acetonide 40mg). A single injection of triamcinolone acetonide 40mg mixed with an equal volume of 1% lidocaine is administered.” NCT07043179 ↗ “Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety.” PMID 36787524 ↗ Feb 2023 “will receive ultrasound-guided intra-articular SIJ injection with 40 mg of Triamcinolone acetonide with a uniform dose of 2 mL of 2% lidocaine hydrochloride .” NCT05134181 ↗ “Patients with CRVO were treated in three groups - with either RON, a single intravitreal injection of 4 mg triamcinolone acetonide, or a placebo treatment.” PMID 22960949 ↗ Sep 2012 “Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide” NCT02515318 ↗ “Periocular triamcinolone acetonide, 40 mg injection may be given either by posterior sub-Tenon's approach or by the orbital floor approach” NCT02374060 ↗ “Triamcinolone acetonide will be the corticosteroid utilized in this study. The triamcinolone acetonide preparation to be used is Kenalog.” NCT00369486 ↗ “Intraoperative subconjunctival injection of triamcinolone acetonide (20mg) delivered 4-5 mm posterior to the limbus at the end of surgery” NCT05157113 ↗ “Triamcinolone acetonide (TA), a topical corticosteroid with potent anti-inflammatory properties, is widely used in the treatment of RAS.” NCT06839313 ↗ “The following drugs will be used for this procedure: 80mg/2ml triamcinolone acetonide (sinakort-A) and 1 mL 0.5% bupivacaine (marcaine)” NCT04212949 ↗ “intraarticular infiltration with 1ml of triamcinolone hexacetonide versus intramuscular injection with 1 ml of triamcinolone acetonide” NCT01447160 ↗ “Combination of intravitreal triamcinolone acetonide (Kenacort-AⓇ) (2mg/0.05ml) and intravitreal bevacizumab (Avastin®) (1.25mg/0.05ml)” NCT04812977 ↗ “Single used, pre-mixed, centrally compounded injectable that contains 15 mg/ml of triamcinolone acetonide and 1 mg/ml of moxifloxacin.” NCT03640650 ↗ “Triamcinolone Acetonide (triamcinolone acetonide cream) is a topical corticosteroid used as anti-inflammatory and antipruritic agent.” NCT00924508 ↗ “The injections will consist of a solution containing 1 ml of 40 mg/ml triamcinolone acetonide and 1 ml of 1% lidocaine in each site.” NCT05980572 ↗ “Intra-operative corticosteroid injection alone was administered around the surgical wound using triamcinolone acetonide (40 mg/ml).” NCT06965088 ↗ “Intradermal triamcinolone acetonide 10 mg/mL, 0.1 mL per 1 cm² square of the affected dermatome, every two weeks for four sessions” NCT07565844 ↗ “3mL lidocaine (without epinephrine) 1% solution combined with 1mL triamcinolone acetonide injectable solution, USP (40mg per mL)” NCT07544576 ↗ “th The OLP on the other side was treated by daily sticking a cut-to-size carrier with 0.05% triamcinolone acetonide for 8 days” NCT04991012 ↗ “triamcinolone acetonide 15 mg / ml with moxifloxacin 1 mg/ml, vancomycin 10 mg/ml to be injected at time of cataract surgery.” NCT02515045 ↗ “Participants will receive a 3.5 ml intra-articular injection of 30mg of hyaluronic acid plus 10mg of triamcinolone acetonide.” NCT04117893 ↗ “patients were randomized to receive triamcinolone acetonide aqueous nasal spray (TAA AQ), 110 microg once daily, or placebo.” PMID 19441606 ↗ Apr 2009 “1 ml of triamcinolone acetonide (40 mg/ml) will be drawn with 1 ml normal saline into a 3 ml syringe and labeled.” NCT05161468 ↗ “PURPOSE: To evaluate the efficacy and safety of intracameral triamcinolone acetonide (TA) in glaucoma surgery.” PMID 24794283 ↗ May 2014 “Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg.” PMID 16978576 ↗ Sep 2006 “one such compound includes triamcinolone acetonide, moxifloxacin hydrochloride and vancomycin (TriMoxiVanc).” NCT02819908 ↗ “Subjects will also be given the nasal steroid Nasacort AQ (triamcinolone acetonide) at a dosage of 220 mcg.” NCT00665977 ↗ “Corticosteroid: 1 ml of triamcinolone acetonide (40mg/ml) mixed with 0.9% NaCl to a total volume of 4 ml.” NCT05737173 ↗ “40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)” NCT02303184 ↗ “40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)” NCT02255032 ↗ “Triamcinolone acetonide administered after ablation as part of the post-procedural injection mixture.” NCT07475689 ↗ “Steroid injection , Triamcinolone acetonide(40mg/ml) 1 ml + 1%Lidocaine without adrenaline 3 ml = 4ml” NCT06453603 ↗ “Corticosteroid agent used is either Dexamethasone 8 mg or Triamcinolone acetonide 0.3-0.6 mg/kg” NCT07713329 ↗ “Standard PAI + 32mg Zilretta (triamcinolone acetonide extended release injectable suspension)” NCT07151417 ↗ “Group (II): triamcinolone acetonide 0.1% ointment, four times daily after meals or rinsing” NCT06988527 ↗ “Hydroquinone 5%, tretinoin 0.05%, triamcinolone acetonide 0.1% once a day during 15 weeks” NCT01085279 ↗ “Group I: Received a combination of 0.1% hyaluronic acid and 0.2% triamcinolone acetonide.” NCT06332365 ↗ “Intra-articular injection of 0.5 cc triamcinolone acetonide (40 mg/cc) within each joint” NCT01382771 ↗ “ultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide” NCT03132051 ↗ “Local corticosteroid injection (triamcinolone acetonide 40mg) as the initial treatment.” NCT07042282 ↗ “Cohort E: Triamcinolone acetonide immediate-release (TCA IR) 40 mg, Final Visit Week 12” NCT02003365 ↗ “topical corticosteroid: triamcinolone acetonide 1% oral gel "Kenacort-A Orabase"” NCT05787925 ↗ “preservative-free intravitreal formulation of triamcinolone acetonide (TAC-PF)” NCT00100009 ↗ “1ml of 40mg/ml triamcinolone acetonide will be mixed with 1ml of normal saline” NCT04812626 ↗ “Postoperative sub-Tenon Triamcinolone Acetonide in glaucoma filtering surgery” NCT00238563 ↗ “Active control topical corticosteroid paste/gel (Triamcinolone acetonide).” NCT07672730 ↗ “40 mg of Kenalog®-40 (triamcinolone acetonide injectable suspension, USP)” NCT02468583 ↗ “Fractional ablative laser followed by Triamcinolone acetonide injection.” NCT06230146 ↗ “Single intraarticular injection of 1cc 40mg/cc triamcinolone acetonide” NCT07515872 ↗ “Triamcinolone acetonide (TAA-AQ) in the double-blind treatment period” NCT00449072 ↗ “Will include 15 patients will injected with triamcinolone acetonide” NCT06729840 ↗ “Injection with 40mg triamcinolone acetonide (kenacort) in the wrist” NCT04755127 ↗ “kenalog in orabase (Triamcinolone acetonide 0.1% in oral paste 5g)” NCT06421038 ↗ “5cc Normal Saline + 2cc 10 mg/ml Triamcinolone Acetonide (Kenalog)” NCT05160441 ↗ “Kenalog - 40 (triamcinolone acetonide injectable suspension, USP)” NCT06793982 ↗ “Triamcinolone acetonide 60mg (3ml)by intramuscular administration” NCT00506896 ↗ “Kanolone Oral Base Paste (Triamcinolone acetonide 0.1%)” NCT06969495 ↗ “Experimental drug is triamcinolone-acetonide 40mg/mL.” NCT03607175 ↗ “Steroid will be Triamcinolone Acetonide (40mg/mL).” NCT05292677 ↗ “triamcinolone acetonide injectable suspension” NCT01692756 ↗ “Corticosteroid (Triamcinolone acetonide)” NCT01874574 ↗ “triamcinolone acetonide 0.1% in orabase” NCT01524744 ↗ “Corticosteroids Triamcinolone Acetonide” NCT06761768 ↗ “Triamcinolone Acetonide From FX006” NCT02637323 ↗ “triamcinolone acetonide 8 mg/mL” NCT04228029 ↗ “Triamcinolone acetonide” NCT04812626 ↗ |
| Known as | Adcortyl | “Drug: Adcortyl” NCT01524744 ↗ |
| Known as | Aristocort C | “This study is a randomized, intraindividual study to evaluate the short-term efficacy of triamcinolone acetonide (Aristocort® C) in subjects with atopic dermatitis.” NCT05844618 ↗1“Triamcinolone Acetonide (Aristocort® C)” NCT07283874 ↗ |
| Known as | CLS-TA | “This open-label study is designed to evaluate the safety of suprachoroidally administered triamcinolone acetone injectable suspension, CLS-TA, in patients with non-infectious...” NCT03097315 ↗2“40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)” NCT02303184 ↗ “40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)” NCT02255032 ↗ |
| Known as | Epirelefan | “triamcinolone acetonide injectable suspension (Epirelefan®, 40mg/ ml, Eipico, Egypt)” NCT06327581 ↗ |
| Known as | FX006 | “FX006 is a novel, microsphere-based, extended-release formulation of triamcinolone acetonide for intraarticular (IA) injection designed to maintain treatment concentration in...” PMID 29088579 ↗ Dec 2017 |
| Known as | ITA | “intravitreal triamcinolone acetonide (ITA)” PMID 19748675 ↗ Sep 2009 |
| Known as | IVT | “comparing intravitreal bevacizumab (IVB) injection alone or in combination with intravitreal triamcinolone acetonide (IVT) versus macular laser photocoagulation (MPC) as a...” PMID 22234244 ↗ Feb 2012 |
| Known as | IVTA | “BACKGROUND: We would assess the efficacy of intravitreal injection of triamcinolone acetonide IVTA combined with standard phacoemulsification on the central subfield macular...” PMID 36401233 ↗ Nov 20221“IMPORTANCE: The Standard of Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study showed that intravitreal triamcinolone acetonide (IVTA) is effective at reducing...” PMID 26086920 ↗ Sep 2015 |
| Known as | kenacort | “Injection with 40mg triamcinolone acetonide (kenacort) in the wrist” NCT04755127 ↗ |
| Known as | Kenacort A Orabase | “The intervention was 0.1% triamcinolone acetonide adhesive paste (Kenacort A Orabase - Dermapharm) and 400 mg Vitamin E capsule (Vitamin E 400 - Pharopharmaceuticles) for the...” NCT04126720 ↗1“triamcinolone acetonide 1% oral gel "Kenacort-A Orabase"” NCT05787925 ↗ |
| Known as | Kenacort TM | “The patients were administered topical corticosteroids in the form of a 0.1% triamcinolone acetonide preparation (Kenacort TM 0.1% Abbott).” NCT06681090 ↗ |
| Known as | KENACORT-A | “Where patients are treated with topical corticosteroids 1 mg/g Triamcinolone acetonide (Kenacort-A orabase 20 G Pomad: Deva dermatological product,Turkey) applied topically 4...” NCT03415165 ↗3“1 mL of triamcinolone acetonide 40 mg (KENACORT-A IM/Intra-articular Retard 40 mg ampoule) and 1 mL of 2% lidocaine (Aritmal 2% ampoule) will be injected over the plantar fascia.” NCT07120204 ↗ “Triamcinolone Acetonide ointment, Kenacort-A orabase” NCT06533033 ↗ |
| Known as | Kenacort-AⓇ | “Combination of intravitreal triamcinolone acetonide (Kenacort-AⓇ) (2mg/0.05ml) and intravitreal bevacizumab (Avastin®) (1.25mg/0.05ml)” NCT04812977 ↗ |
| Known as | Kenacourt-A Orabase | “0.1% topical triamcinolone Acetonide preparation "Kenacourt-A Orabase"” NCT06681090 ↗ |
| Known as | Kenacourt-A Orabase Pomad | “0.1 % topical triamcinolone acetonide preparation (Kenacourt-A Orabase Pomad, DEVA HOLDINGS A.S., Istanbul, Turkey) was used where the patients' were instructed to apply the...” NCT03572959 ↗ |
| Known as | Kenalog | “Participants will receive one ultrasound-guided injection with 1 ml Kenalog 40mg/ml and 1 ml Lidocaine 10mg/ml superficial to the insertion of the gluteus medius and minimus...” NCT06456099 ↗35“Epidural steroid injectate will be 2cc of 1% lidocaine followed by 1-3 cc of 40 mg/cc Kenalog (i.e. 40-120 mg Kenalog) or an equivalent steroid medication (depo-medrol 60-120...” NCT01238536 ↗ “heparin sulphate 40,000 IU (4 cc of 10,000 units/cc), lidocaine 2% 16 ml, Sodium bicarbonate 8.4% 4 ml and Kenalog 40 mg (1cc) to reach a total fluid volume of 25 ml will be...” NCT02870738 ↗ “Material identification: Celestone soluspan or Kenalog 1% 50mL multiuse vials without epinephrine, 1% 5mL lidocaine vials, 10mL syringes with 21mm x 1 ¼ inch needles, alcohol...” NCT03445611 ↗ “5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl...” NCT06793982 ↗ “* Trigger finger/De Quervain's tenosynovitis/Tendonitis: 20mg kenalog (0.5mL of kenalog 40mg/mL suspension) + 5mg lidocaine (0,5mL 10mg/mL lidocaine solution)” NCT06188221 ↗ “Patients assigned to Steroid group will receive 80mg of Triamcinolone Acetonide (Kenalog) mixed with 8mL of 1% lidocaine with epinephrine 1:100,000.” NCT03319784 ↗ “The corticosteroid is prepared in a 10 ml syringe by combining 1-2 mL Kenalog \[40 mg/dL\], 6-8 mL sterile normal saline, 3-4 mL Ropivicaine 1%.” NCT05288725 ↗ “The triamcinolone preparation commonly injected into the eye is Kenalog and is FDA-approved only for use in muscles and joints.” NCT00105027 ↗ “A 6ml solution of 4ml 0.25% Bupivacaine, 1ml 40mg Kenalog, and 1ml 4mg Dexamethasone will be prepared.” NCT01688362 ↗ “Participants in the corticosteroid group will recieve corticosteroid injections (1 cc Kenalog 10 mg).” NCT01897259 ↗ “A 6mL injection at the initial visit of triamcinolone 40 mg/1 mL (Kenalog) with 5 mL of 1% lidocaine” NCT05657496 ↗ “Intravesical lidocaine, heparin, sodium bicarb, Kenalog, gentamicin” NCT05658874 ↗ “5cc Normal Saline + 2cc 10 mg/ml Triamcinolone Acetonide (Kenalog)” NCT05160441 ↗ “Kenalog {0.4 ml, 10mg/ml, triamcinolone acetonide}” NCT06681688 ↗ “1cc kenalog corticosteroid (40mg/cc)” NCT01123889 ↗ “triamcinolone acetonide (Kenalog)” NCT00411333 ↗ “3. Kenalog 10 mg/ml - 5 ml” NCT03105674 ↗ “Bupivacaine, kenalog” NCT03291197 ↗ “Kenalog” NCT03196310 ↗ |
| Known as | Kenalog in orabase | “Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g)” NCT06910579 ↗ |
| Known as | Kenalog-10 | “Intralesional injections of 4mLs Triamcinolone Acetonide 10 mg/mL (Kenalog-10) on the whole scalp” NCT01797432 ↗2“5ml 1% Lidocaine + 1ml 40mg Kenalog®-10 into the shoulder joint” NCT00742846 ↗ “Triamcinolone Acetonide 10 mg/mL (Kenalog-10)” NCT00484679 ↗ |
| Known as | Kenalog-40 | “5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl...” NCT06793982 ↗4“5 milliliters (mL) injection of corticosteroid (1cc Kenalog, 4cc Xylocaine) Kenalog - 40 (triamcinolone acetonide injectable suspension, USP) Xylocaine - MPF (lidocaine HCl...” NCT06703970 ↗ “Subjects in the Experimental Group will received a 2 mL injection consisting of 1 mL of 0.5% bupivacaine (5 mg bupivacaine-HCL) and 1 mL Kenalog-40 (40 mg triamcinolone acetonide).” NCT05178485 ↗ “Kenalog-40 is a long-acting corticosteroid injection for intramuscular (into the muscle) or intra-articular (into the joints) use.” NCT06712290 ↗ “Name: Kenalog®-40 (triamcinolone acetonide injectable suspension)” NCT06478186 ↗ |
| Known as | Nasacort AQ | “Subjects will also be given the nasal steroid Nasacort AQ (triamcinolone acetonide) at a dosage of 220 mcg.” NCT00665977 ↗1“Triamcinolone acetonide aqueous (TAA-AQ) nasal spray (NASACORT AQ)” NCT01154153 ↗ |
| Known as | RETAAC | “Phase I/II study with intravitreal triamcinolone acetonide microspheres(RETAAC)for treatment of diffuse diabetic macular edema unresponsive to laser photocoagulation.” NCT00407849 ↗ |
| Known as | SCS-TA | “A novel triamcinolone acetonide (TA) injectable suspension formulated for administration to the SCS, SCS-TA (Xipere®; Bausch + Lomb), received FDA approval in 2021 for the...” PMID 36787524 ↗ Feb 2023 |
| Known as | SCTA | “OBJECTIVE: To determine the efficacy of intravitreal bevacizumab (IVB) monotherapy versus a combination of IVB and suprachoroidal triamcinolone acetonide (SCTA) followed by...” PMID 42369925 ↗ Jun 2026 |
| Known as | Shincort | “The steroid injection was using 1ml of 10 mg (10mg/ml) triamcinolone acetonide (Shincort) mixed with 1 ml of 2% lidocaine hydrochloride (Xylocaine).” NCT02708693 ↗4“ultrasound guided steroid injection using 1ml of 10mg triamcinolone acetonide (Shincort) mixed with 1ml of 2% lidocaine hydrochloride (Xylocaine)” NCT04346030 ↗ “2 ml SHINCORT INJ 10 MG/ML + 2 ml 2% Xylocaine” NCT06165939 ↗ |
| Known as | sinakort-A | “The following drugs will be used for this procedure: 80mg/2ml triamcinolone acetonide (sinakort-A) and 1 mL 0.5% bupivacaine (marcaine)” NCT04212949 ↗ |
| Known as | Stacort-A | “Stacort-A Triamcinolone Acetonide 40mg” NCT07006168 ↗ |
| Known as | TA-ER | “INTRODUCTION: The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA-ER) in patients with...” PMID 30741382 ↗ Feb 20192“Triamcinolone acetonide extended-release (TA-ER) suspension is novel and composed of polylactic-co-glycolic acid microspheres which allows for timed release of the steroid over...” NCT06237153 ↗ “Name: ZILRETTA (triamcinolone acetonide extended-release injectable suspension; TA-ER)” NCT06478186 ↗ |
| Known as | TA-IR | “Active Ingredient: Triamcinolone Acetonide- Immediate Release (TA-IR)” NCT06478186 ↗ |
| Known as | TAA-AQ | “This study was designed to determine the effect of 6-week triamcinolone acetonide aqueous (TAA-AQ) nasal spray treatment on HPA axis function” PMID 24717794 ↗ Mar 20142“patients were randomized to receive triamcinolone acetonide aqueous nasal spray (TAA AQ), 110 microg once daily, or placebo.” PMID 19441606 ↗ Apr 2009 “Triamcinolone acetonide (TAA-AQ) in the double-blind treatment period” NCT00449072 ↗ |
| Known as | TAAC | “For transition to suprachoroidal injection of Triamcinolone Acetone (TAAC) a diagnosis of resistant DME is required.” NCT04690608 ↗ |
| Known as | TAC | “OBJECTIVE: To compare levels of triamcinolone acetonide (TAC) in perilymph and plasma after intratympanic injection.” PMID 34591079 ↗ Nov 20213“Triamcinolone Acetanoide (TAC) which is the existing standard of care in sub-Saharan Africa” NCT04391621 ↗ “the current approved steroid treatment for keloids, triamcinolone acetonide (TAC)” NCT01978301 ↗ “Group A: Intralesional (IL) triamcinolone acetonide (TAC) alone;” NCT04812626 ↗ |
| Known as | TAC DuraPeel | “Triamcinolone Acetonide (TAC) DuraPeel” NCT00890968 ↗ |
| Known as | TAC-PF | “The purpose of this study is to evaluate the long-term safety and potential efficacy of novel intravitreal injections of a preservative-free formulation of triamcinolone...” NCT00101764 ↗3“preservative-free intravitreal formulation of triamcinolone acetonide (TAC-PF)” NCT00100009 ↗ “Preservative-Free Triamcinolone Acetonide (TAC-PF)” NCT00464347 ↗ “Triamcinolone Acetonide (TAC-PF)” NCT00071227 ↗ |
| Known as | TCA | “This open-label, parallel-arm, healthy volunteer study assessed potential short-term safety, tolerability and pharmacokinetic (PK) interactions between IA LOR and triamcinolone...” PMID 37902943 ↗ Oct 2023 |
| Known as | TCA-ER | “triamcinolone acetonide extended-release injectable suspension; TCA-ER” NCT06478186 ↗ |
| Known as | TCA-IR | “Cohort E: Triamcinolone acetonide immediate-release (TCA IR) 40 mg, Final Visit Week 12” NCT02003365 ↗1“Triamcinolone Acetonide- Immediate Release;TCA-IR” NCT06478186 ↗ |
| Known as | TRI | “The study compared the clinical effectiveness of topical Tacrolimus (TAC) in patches or gel with Triamcinolone acetonide (TRI) gel for erosive/atrophic oral lichen planus (OLP)” PMID 36788511 ↗ Feb 2023 |
| Known as | Triamcinalone Acetonide | “preoperative Triamcinalone Acetonide (TA)” NCT00238563 ↗ |
| Known as | Triamcinolonacetonid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01109446 ↗ |
| Known as | Triamcinolone | “Triamcinolone acetonide mucoadhesive films 1 mg every 6 hours for two weeks.” NCT02453503 ↗3“Intralesional injections of 0.4mg/cc triamcinolone once a week” NCT03365141 ↗ “Kenalog-40 (triamcinolone 40mg)” NCT02613455 ↗ “Kenalog (Triamcinolone)” NCT02519738 ↗ |
| Known as | Triamcinolone Acetanoide | “Triamcinolone Acetanoide (TAC) which is the existing standard of care in sub-Saharan Africa” NCT04391621 ↗ |
| Known as | triamcinolone acetonide 10mg/mL (Shincort, YSP, Taiwan) | “triamcinolone acetonide 10mg/mL (Shincort®, YSP, Taiwan)” NCT01950793 ↗2“triamcinolone acetonide 10mg/ml (shincort, YSP, Taiwan)” NCT03072290 ↗ “triamcinolone acetonide 10mg/ml (Shincort, YSP, Taiwan)” NCT04364425 ↗ |
| Known as | Triamcinolone Acetonide Acetate and Urea Cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04994951 ↗ |
| Known as | Triamcinolone acetonide aqueous | “This study was designed to determine the effect of 6-week triamcinolone acetonide aqueous (TAA-AQ) nasal spray treatment on HPA axis function” PMID 24717794 ↗ Mar 2014 |
| Known as | triamcinolone acetonide extended-release | “INTRODUCTION: The aim of this work is to assess the safety and efficacy of repeat administration of triamcinolone acetonide extended-release (TA-ER) in patients with...” PMID 30741382 ↗ Feb 2019 |
| Known as | Triamsinolon asetonid | “% 0,1 Triamsinolon asetonid (Kenacort- A orabase pomad) will be used on ulcer areas 4 times a day (after meals and before going to bed) for 7 days.” NCT06839313 ↗ |
| Known as | Triescence | “and Triescence (triamcinolone acetonide) in treatment-naïve patients with Exudative Age-Related Macular Degeneration.” NCT04075136 ↗ |
| Known as | Xipere | “A novel triamcinolone acetonide (TA) injectable suspension formulated for administration to the SCS, SCS-TA (Xipere®; Bausch + Lomb), received FDA approval in 2021 for the...” PMID 36787524 ↗ Feb 2023 |
| Known as | Zilretta | “Triamcinolone acetonide extended-release (TA-ER) suspension is novel and composed of polylactic-co-glycolic acid microspheres which allows for timed release of the steroid over...” NCT06237153 ↗11“Generic Name: Triamcinolone acetonide Zilretta is an extended-release synthetic corticosteroid indicated as an intra-articular injection for the management ofosteoarthritis...” NCT05492851 ↗ “Zilretta (Triamcinolone acetonide extended-release injectable suspension) is indicated as an intra-articular injection for the management of pain due to knee OA.” NCT05058209 ↗ “Zilretta®, triamcinolone acetonide extended release suspension 32 mg, is a microsphere formulation of injectable steroid” NCT04831255 ↗ “Standard PAI + 32mg Zilretta (triamcinolone acetonide extended release injectable suspension)” NCT07151417 ↗ “Name: ZILRETTA (triamcinolone acetonide extended-release injectable suspension; TA-ER)” NCT06478186 ↗ |
| Action | Inhibit | “can inhibit the expression of VEGF” NCT05464953 ↗ |
| Modality | Other / unclassified | “The use of intravitreal injections of corticosteroid (triamcinolone acetonide) appears to be a promising treatment for a variety of ocular diseases associated with inflammation.” NCT00101764 ↗ |
| Route | Intravitreal | “receive via intravitreal injection” NCT00071227 ↗ |